For this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy’ designation from the US FDA.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
For this approval, Jubilant is eligible for 180 days of exclusivity through the ‘Competitive Generic Therapy’ designation from the US FDA.
| Subscribe To Our Free Newsletter |
